-transparent.png){kind=logo}
Repeated administration of long acting analogues of gonadotrophin releasing hormone diminishes gonadal function and in men decreases testosterone concentrations; for this reason the effect of the analogue buserelin was studied in prostatic carcinoma. Twelve consecutive patients with newly diagnosed locally advanced or metastatic carcinoma of the prostate were treated. Each patient received intranasal buserelin in divided dosages of either 600 or 1000 micrograms daily. Suppression of the gonadotrophins and testosterone occurred in all patients. Objective and subjective signs of regression of disease were seen in nine patients. Buserelin offers an effective treatment of metastatic prostatic cancer without the side effects and cardiovascular risks associated with oestrogen treatment.
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
December 1985,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
June 1998,
Bailliere's clinical obstetrics and gynaecology,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
October 1991,
British journal of obstetrics and gynaecology,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
April 1989,
Cancer,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
February 1985,
British medical journal (Clinical research ed.),
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
February 1994,
Tumori,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
June 1983,
The Journal of urology,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
August 1988,
Seminars in oncology,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
August 1992,
Drug and therapeutics bulletin,
J H Waxman, and
J A Wass, and
W F Hendry, and
H N Whitfield, and
G M Besser, and
J S Malpas, and
R T Oliver
July 1989,
Israel journal of medical sciences,
